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Abstract: Fluorination of 3,5-diarylpyrazole substrates by 
SelectfluorTM in acetonitrile  gave  4,4-difluoro-1H-pyrazoles  
in addition to 4-fluoropyrazole derivatives. The structure of this 
new class of fluorinated heterocycle was established by X-ray 
crystallography. 
Key words: organofluorine; fluoroheterocycle; pyrazole; 
selective fluorination; fluoropyrazole. 
4,4-Difluoro-1H-pyrazole systems, a new class of 
fluorinated heterocycle, were synthesised by reaction 
of the corresponding diaryl-pyrazole and electrophilic 
fluorinating agent Selectfluor
TM
. 
The importance of fluorine containing aromatic and 
heterocyclic motifs to the pharmaceutical and 
agrochemical industries continues to grow
1
 because 
approximately 5-15% of the total number of drugs 
launched worldwide over the past 50 years bear 
fluorinated substituents.2 For example, many 6-
membered fluorinated heteroaromatic derivatives find 
applications in a wide variety of drugs and plant 
protection agents such as Xeloda (anti-cancer, Roche), 
Voriconazole (antifungal, Pfizer), Ancobon 
(antifungal, Valeant) and Diclosulam (herbicide, Dow 
Agroscience).
2
  
Whilst there are many reported examples of the 
synthesis of commercially important fluorinated 6-
membered aza-heterocyclic rings, processes for the 
preparation of related fluorinated 5-membered ring 
systems are relatively rare.
3
 However, interest in 
fluoropyrazole derivatives has increased recently due 
to their potential use for treating diabetes,
4
 
inflammatory disease,
5
 as gastric acid inhibitors
6
 and 
as acaricides.
7
 Consequently, protocols for the 
synthesis of a variety of selectively fluorinated 
pyrazoles have been reported using either fluorination 
or ‘fluorinated building block’ strategies. Fluoro-
cyclocondensation reactions involving enamino 
ketones
8
 and fluorocyanoketones,
9
 gold catalysed 
aminofluorination of alkynes
10
 and reaction of 
hydrazines with fluoro--dicarbonyl substrates
11
 offer 
efficient routes to various functional fluoropyrazole 
derivatives. Adaptation of established fluorination 
methodology such as halogen exchange
12
 or Balz-
Schiemann processes
13
 has had limited success for the 
synthesis of fluoropyrazoles from appropriately 
functionalised pyrazole substrates due to low total 
yields over several synthetic steps. Potentially, the 
most efficient methods for the synthesis of 
fluoropyrazole systems are aromatic substitution 
processes using electrophilic fluorinating agents. A 
few examples of the preparation of various 
fluoroaminopyrazole systems from the reaction of 
aminopyrazole precursors with NFSI or Selectfluor
TM
 
have been recorded
14
 whilst several 4-fluoropyrazole 
derivatives have been prepared by reaction of 
Selectfluor
TM
 with a range of N-arylpyrazole 
substrates.
15
 
As part of a wider research programme concerning the 
synthesis of fluoroorganic systems using electrophilic 
fluorinating agents,
16
 we were interested in 
broadening the scope of ‘late-stage’ fluorination 
reactions of pyrazole derivatives for applications in 
the life-sciences industries. In this paper, we describe 
electrophilic fluorination reactions of various pyrazole 
derivatives with either Selectfluor
TM
 or fluorine gas 
which led to the unexpected synthesis of novel 4,4-
difluoro-1H-pyrazole systems.  
Pyrazole substrates 1 were either obtained from 
commercial suppliers or synthesised by reaction of the 
appropriate diketone derivatives with hydrazine or 
phenyl hydrazine by heating to reflux in ethanol 
following literature procedures.
17
  
We began our pyrazole fluorination studies by 
investigating reactions of representative pyrazole 
systems 1a-c with either Selectfluor
TM
 or fluorine gas 
and the results are collated in Table 1. Reactions 
involving Selectfluor
TM
 were carried out by heating 
the reaction mixture by using microwave irradiation 
(Conditions A). Fluorine gas, diluted to a 10% mixture 
(v/v) in dry nitrogen was passed at a controlled rate 
via a mass flow controller into a stirred solution of the 
substrate in acetonitrile using equipment discussed 
previously (Conditions B).
16
 Mono-fluorinated 
pyrazoles 2a-c were formed in modest yields and 
could be purified by column chromatography on silica 
gel. In contrast, fluorination of 3,5-dimethyl-1H-
pyrazole was very inefficient due to extensive tar 
formation due to competing fluorination of the 
pendant methyl substituents and subsequent product 
degradation. In addition, pyrazole systems bearing 
two electron-withdrawing groups (CF3, CO2H, 
CO2Me), gave no observed products upon reaction 
with either Selectfluor
TM
 or fluorine gas, reflecting the 
lower nucleophilicity of these substrates, and starting 
materials were recovered in all of these reactions.  
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Monofluoro-pyrazole systems 2a-c were identified by 
NMR and mass spectrometry techniques. In particular, 
the 
19
F NMR spectra of these systems display singlet 
resonances at approximately -175 ppm, consistent 
with reported spectroscopic data reported for related 
fluoropyrazole systems.
15
 In addition, the structure of 
2b was confirmed by X-ray crystallography (Fig. 1).
18
 
Table 1 Synthesis of monofluoro-pyrazoles 2 using Selectfluor
TM
 
or fluorine gas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Molecular structure of 2b 
In order to expand the scope of the fluorination 
reactions we studied reactions of diphenylpyrazole 
substrates 1d-k which unexpectedly gave mixtures of 
mono- and di- fluorinated systems 2d-k and 3a-h even 
when only one equivalent of Selectfluor
TM
 was used 
and these results are collated in Table 2 (Conditions 
A). In all reactions, separation and purification of the 
difluorinated products 3a-h were readily achieved 
because, in general, they eluted from the silica gel 
column much more rapidly than the starting material 
and mono-fluorinated pyrazole systems. Separation of 
fluoropyrazole products from the corresponding 
starting materials proved to be very difficult but could 
be achieved in several cases. Yields of the 4,4-
difluoro-1H-pyrazole products 3a-h were improved 
upon reaction of the pyrazole substrates with two 
equivalents of Selectfluor
TM
. (Table 2, Conditions C). 
Table 2 Synthesis of fluoropyrazole and 1H-difluoropyrazole 
derivatives 
*Products 2e-h could not be separated from starting materials 1e-h 
respectively by column chromatography and yields were estimated 
by 19F NMR in these cases only. 
In contrast, when 3,5-diarylpyrazoles 1d-k were 
reacted with fluorine gas, many fluorinated products 
were observed by 
19
F NMR analysis of the crude 
product mixture and no products could be isolated and 
purified. In these reactions, competing fluorination of 
the aromatic ring substituents occurs as determined by 
the observation of many signals in the aromatic region 
(δF -140 -160 ppm) of the 
19
F NMR spectra of the 
crude product mixture. 
Difluorinated products 3a-h were characterized by 
distinctive singlet resonances at approximately -115 
ppm in their 
19
F NMR spectra and the structure of 3f 
was confirmed by X-ray crystallography (Fig. 2).
18
 
The difluorinated pyrazole systems 3 are a novel class 
of fluorinated compounds although corresponding 
dichlorinated systems have been reported and their use 
in Diels-Alder reactions has been explored.
19
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Figure 2 Molecular structure of 3f 
Initial fluorination of pyrrole derivatives occurs 
selectively at the 4-position consistent with an 
electrophilic aromatic substitution process (Scheme 1) 
and further electrophilic fluorination reaction occurs  
at the same site to give a difluorinated salt 4 as an 
intermediate. Deprotonation on work-up gives the 
observed 4,4-difluoro-1H pyrazole product 3. 
 
Scheme 1 Fluorination of pyrazole derivatives 2 and 3 
The intermediate carbocation 4b is stabilized by the 
adjacent phenyl groups (R1 = Aryl, Scheme 1) 
allowing difluorination to proceed as observed for 3,5-
diarlpyrazole substrates. 
In some cases a hydroxylated pyrazoline intermediate 
such as 5 was observed in crude product mixtures by 
19
F NMR analysis and, for reaction with dibrominated 
system 1l, the hydroxyl-pyrazoline 5 could be isolated 
albeit in low yield. This minor product is formed by 
reaction of water with intermediate salt 4 in reaction 
work-up, consistent with the mechanism shown in 
Scheme 1 and related reactions involving other 
halogenated 4H-pyrazoles.
20
 The hydroxyl-pyrazoline 
product 5 could be identified by the presence of an AB 
system, with an appropriate JAB 128 Hz coupling 
constant, in the 
19
F NMR spectrum.  
 
Scheme 2 Hydoxylated pyrazoline 5 
In conclusion, a method for the synthesis of unusual 
4,4-difluoro-1H-pyrazole systems 3 has been 
established using shelf-stable, readily handled 
Selectfluor
TM
 as the electrophilic fluorinating agent. 
 
 
 
Experimental Section 
Typical procedure (Conditions A)  
4-Fluoro-3,5-diphenyl-1H-pyrazole 2d and 4,4-
difluoro-3,5-diphenyl-4H-pyrazole 3a 
3,5-Diphenyl-1H-pyrazole (0.30 g, 1.36 mmol) and 
Selectfluor
TM
 (0.482 g, 1.36 mmol) were dissolved in 
acetonitrile (5 mL) and the mixture heated by 
microwave irradiation for 15 minutes at 90 °C. The 
mixture was then extracted with DCM (3 x 50 mL) 
and washed with sodium bicarbonate (30 mL) and 
water (30 mL). The combined extracts were dried 
(MgSO4) and evaporated. Column chromatography on 
silica gel using hexane and ethyl acetate (1 : 1) as the 
eluent, gave 4-fluoro-3,5-diphenyl-1H-pyrazole (0.135 
g, 45 %) as pale yellow crystals; m.p. 185-188 °C 
(Found: [MH]
+
, 239.0972. C15H11FN2 requires: 
[MH]
+
, 239.0983); 
1
H NMR (400 MHz; CDCl3): δ 
7.41-7.47 (2H, m, 4-H), 7.48-7.51 (4H, m, 3-H), 7.77-
7.80 (4H, m, 2-H), 10.3 (1H, bs, NH); 
13
C NMR (126 
MHz; CDCl3): δ 128.2 (Ar), 129.0 (Ar), 129.3 (Ar), 
131.1 (d, 
2
JCF 15.0, C-3), 140.0 (d, 
1
JCF 226.6, C-4), 
148.7 (Ar); 
19
F NMR (376 MHz; CDCl3): δ -174.3 (s); 
m/z (EI
+
) 237.9 ([M]
+
, 100 %), 107.8 (43), 76.9 (40); 
and, 4,4-difluoro-3,5-diphenyl-4H-pyrazole 3a (0.122 
g, 21%) as yellow crystals; m.p. 105–107 °C; (Found 
[MH]
+
, 257.0894. C15H10F2N2 requires: [MH]
+
, 
257.0890); 
1
H NMR (400 MHz; CDCl3): δ 7.67–7.44 
(6H, m, Ar-H), 8.15–8.06 (4H, m, Ar-H); 
13
C NMR 
(126 MHz; CDCl3): δ 125.4 (Ar), 125.6 (t, 
1
JCF 267.5, 
CF2), 128.3 (Ar), 129.5 (Ar), 133.1 (Ar), 162.1 (t, 
2
JCF 
23.1, C-2); 
19
F NMR (376 MHz; CDCl3): δ -116.3 (s); 
m/z (EI
+
) 256.1 ([M]
+
, 100 %), 153.0 (45), 103.1 (99), 
77.1 (36). 
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